# Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo

> **NCT03358082** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sohag University** · enrollment: 100 (estimated)

## Conditions studied

- Vitiligo
- Tacrolimus

## Interventions

- **DRUG:** Tacrolimus 0.03% Ointment
- **DRUG:** Hydrocortisone Acetate 1% Ointment

## Key facts

- **NCT ID:** NCT03358082
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358082, "Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03358082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*